Moleculera Labs, Inc.
A neuroimmunology diagnostics company focused on changing how medicine is practiced for neuropsychiatric and behavioral disorders
60MM Americans suffer from neuropsychiatric and developmental disorders treated with neuropsychiatric drugs, often with little improvement. We are a precision medicine company directing treatment to an underlying immune dysfunction. Patients experience remarkable recoveries when properly diagnosed and treated. These include PANDAS/PANS, autism, ADD/ADHD, anxiety disorder and others. Generating $7.5MM in cumulative revenue on $5.5MM investment.